Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
INNOVENT BIO Completes Introduction of Takeda, Raising ~HKD780M Net
Recommend 8 Positive 11 Negative 3 |
||||
|
||||
|
In October 2025, INNOVENT BIO (01801.HK) announced a global strategic partnership with Takeda Pharmaceutical (4502.JP). This partnership involves a licensing agreement valued at USD11.4 billion and a USD100 million strategic equity investment from Takeda. INNOVENT BIO announced that all conditions precedent to each of the license, option and collaboration agreement have been fulfilled or waived, and the share issuance agreement was completed yesterday (4th). It issued a total of 6.9138 million shares (around 0.4% of its issued share capital) to Takeda, with net proceeds amounting to nearly HKD780 million. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
